Tricog Healthcare Services Private Limited

Tricog Healthcare Services Private Limited, based in India, operates as a technology-driven company specializing in advanced cardiac care solutions, aiming to improve diagnostic processes in healthcare. Founded in 2014 in Bangalore, India, Tricog Healthcare Services Private Limited focuses on enhancing cardiac care delivery through innovative technology. The company was established by Charit Bhograj, Udayan Dasgupta, and Zainul Charbiwala. As of March 2023, Tricog raised USD 8.

50 mn in Series B funding, led by Omron Healthcare, Inc. , with participation from Inventus Capital Partners, SGInnovate, Sony Ventures, and The University of Tokyo Edge Capital Partners. This funding round brought the total amount raised by the company to USD 8. 50 mn, with a current valuation of USD 76.

51 mn. Tricog Healthcare specializes in advanced cardiac care solutions, utilizing medical-grade artificial intelligence and technology to enhance diagnostic and treatment processes in healthcare. Their core offerings, including InstaECG and InstaEcho, facilitate timely and accurate ECG diagnoses, addressing gaps in cardiac care, especially in underserved areas. The solutions are utilized by healthcare providers such as clinics and hospitals in India and select international markets, aiming to reduce mortality rates associated with cardiovascular diseases and improve patient outcomes.

Tricog Healthcare operates through a business-to-business model, partnering with healthcare organizations for efficient cardiac care solutions. In 2023, the company's revenue reached USD 808,845. 70, with an EBITDA of USD 196,529. 70.

Revenue is generated through subscription-based services and direct sales of proprietary medical devices, tailored to meet the needs of healthcare providers while ensuring quality in cardiac diagnostics. In March 2023, Tricog Healthcare Services Private Limited raised USD 8. 50 mn in Series B funding to expand its reach to Asia and Africa, while strengthening its presence in the US healthcare market. The company plans to develop new products aimed at improving cardiac care solutions and is actively working on strategies for market penetration in these regions.